logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The Dow opened down 0.1%, the S&P 500 down 0.1%, and the Nasdaq down 0.2%.

date
07/11/2025
Meiwei Technology rose by 5.5%, with reports that SoftBank is considering merging it with Arm. Lyft rose by 5.0%, with expectations that Q4 total bookings will exceed expectations. Stagwell rose by 41.2%, announcing a partnership with Palantir. Qualcomm fell by 2.6%, with the company stating that the modem business will lose Apple as a customer.
Latest
1 m ago
Lilly (LLY.US) and Novo Nordisk (NVO.US) both announced a straight line increase and reached an agreement with the US government to lower the price of GLP-1 while also obtaining a three-year tariff exemption. Senior officials of the Trump administration stated that approximately 10% of federal Medicare patients will be eligible to expand the use of GLP-1.
3 m ago
Senior officials of the Trump administration: Commercial health insurance companies will also be able to obtain GLP-1 medications at lower prices.
3 m ago
Senior official in the Trump administration: Commercial health insurance companies may see GLP-1 drug prices 25% lower than cash market prices and most favored nation prices.
4 m ago
Nord and Nord: Negotiations under the framework of the White House agreement and the "Lowering Inflation Act" are independent of each other.
4 m ago
The US government, Eli Lilly and Novo Nordisk announced an agreement to lower the price of GLP-1 weight loss drugs. Both companies will price it at $245 per month.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.